This company has been acquired
Chembio Diagnostics Dirección
Dirección controles de criterios 2/4
Información clave
Richard Eberly
Chief Executive Officer (CEO)
US$1.6m
Compensación total
| Porcentaje del salario del CEO | 28.6% |
| Permanencia del CEO | 3.1yrs |
| Participación del CEO | 1.0% |
| Permanencia media de la dirección | 2.2yrs |
| Promedio de permanencia en la Junta Directiva | 2.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Chembio gets $3.2M contract from CDC to develop rapid test for syphilis
Sep 06Chembio stock rises 13% amid plans to develop rapid test for monkeypox
Aug 16Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?
Nov 30
Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher
Aug 08Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?
Jul 22Chembio Diagnostics EPS beats by $0.10, beats on revenue
May 06Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?
Apr 07Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?
Jan 16Chembio stock gains after COVID-19 tests nab European Union nod
Jan 14Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?
Dec 12
Chembio slumps 13% on delay of U.S. nod for coronavirus antibody test
Dec 04Chembio nabs BARDA contract for rapid respiratory antigen panel test
Dec 02Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2022 | US$2m | US$460k | -US$23m |
| Sep 30 2022 | n/a | n/a | -US$36m |
| Jun 30 2022 | n/a | n/a | -US$36m |
| Mar 31 2022 | n/a | n/a | -US$38m |
| Dec 31 2021 | US$2m | US$477k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$27m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | n/a | n/a | -US$25m |
| Dec 31 2020 | US$1m | US$315k | -US$26m |
Compensación vs. Mercado: Richard's total compensation ($USD1.61M) is above average for companies of similar size in the US market ($USD767.83K).
Compensación vs. Ingresos: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Eberly (61 yo)
3.1yrs
Permanencia
US$1,610,406
Compensación
Mr. Richard L. Eberly serves as the President and Chief Executive Officer at Chembio Diagnostics, Inc. since March 16, 2020 and has been its Director since May 02, 2020. He joined Chembio in March, 2020. H...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.1yrs | US$1.61m | 1.03% $ 171.6k | |
| Executive VP | 1.3yrs | US$1.05m | 0.15% $ 24.4k | |
| Executive VP and Chief Scientific & Technology Officer | 19.3yrs | US$765.96k | 0.50% $ 84.2k | |
| Executive VP & COO | 3yrs | sin datos | 0.021% $ 3.6k | |
| Vice President of Human Resources | 1.4yrs | sin datos | sin datos | |
| Senior Vice President of Global Commercial Operations | 1.3yrs | sin datos | 0.021% $ 3.6k |
2.2yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: CEMI's management team is considered experienced (2.2 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 2.9yrs | US$1.61m | 1.03% $ 171.6k | |
| Independent Director | less than a year | US$143.43k | sin datos | |
| Independent Director | 4.9yrs | US$100.31k | 0.15% $ 24.6k | |
| Independent Chairperson | 15.9yrs | US$123.89k | 0.31% $ 52.0k | |
| Independent Director | 2.3yrs | US$91.56k | 0.040% $ 6.7k | |
| Independent Director | 2.1yrs | US$94.06k | 0.031% $ 5.2k |
2.6yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: CEMI's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.